Mining the code of life for new antibiotics

Area of Science:

• Drug Discovery and Development
• Microbiology and Infectious Diseases
• Computational Chemistry and Bioinformatics

Background:

• Antimicrobial resistance (AMR) is a growing global health threat, outpacing the development of new antibiotics.
• Traditional methods like "dirt mining" and phenotypic screening are insufficient for discovering novel antimicrobials at the required pace and scale.

Purpose of the Study:

• To review the evolution of antibiotic discovery strategies from classical approaches to modern digital and AI-driven platforms.
• To highlight how computational and genomic methods are expanding the scope and efficiency of identifying novel antibacterial agents.

Main Methods:

• Exploration of advanced cultivation techniques (in situ, co-culture, microfluidics) to access uncultured microbes.
• Application of computational approaches including virtual screening, molecular networking, and deep learning for scaffold identification.
• Genomic and metagenomic mining for antimicrobial peptides and biosynthetic gene clusters.
• Utilizing generative AI for designing peptides and small molecules with optimized properties.

Main Results:

• Digital discovery platforms enable systematic exploration of vast chemical and biological spaces.
• Novel antibacterial scaffolds and compounds have been identified using computer-aided and genomic methods.
• Generative AI facilitates the design of drug candidates with improved potency, safety, and resistance profiles.

Conclusions:

• The integration of digital and AI technologies represents a paradigm shift in antibiotic discovery.
• These advanced platforms enhance the novelty, efficiency, and durability of antimicrobial agents against AMR.
• Future antibiotic innovation relies on these systematic, engineerable approaches to combat resistance.